NFKB1 and rheumatoid arthritis: Nevertheless, the observed differences in the levels of circulating CS/DS between patients with JIA and those with osteoarthritis or rheumatoid arthritis may indicate a possible reason for the different clinical courses of these diseases, as glycans are known modulators of the NFκB pathway, which is a key player in inflammation [34].